YR-001(Yipinhong Pharmaceutical Co Ltd)

N/A

Report date: 2025/09/25 17:32:33
NME

Base Information

Drug NameYR-001(Yipinhong Pharmaceutical Co Ltd)
Drug Alias NameYR-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsCardiovascular DiseasesCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYipinhong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYipinhong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCerebrovascular Disorders
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A